People who are transgender and lack access to insurance coverage for gender-affirming hormone therapy are more likely to turn to sources other than a licensed health care provider, a new Michigan Medicine-led study finds.
Tag: Insurance Coverage

JNCCN Study Explores if Insurance is Keeping Pace with Trends in Targeted Cancer Therapy
New research from the University of California, San Francisco (USCF) and City of Hope in the July 2020 issue of JNCCN—Journal of the National Comprehensive Cancer Network examines coverage trends for circulating tumor DNA testing, also known as gene sequencing of ctDNA or “liquid biopsies.” The researchers found coverage rate rose from 0% to 38% in three years. The policies also increased in scope from 2017-2019, going from one cancer type to 12.
AED and STRIPED Team Up with Deloitte to Conduct a Comprehensive US Economic Impact Study
AED and STRIPED Team Up with Deloitte to Conduct a Comprehensive US Economic Impact Study